Acupuncture ineffective in treating PCOS-induced infertility: Study

Image
ANI Washington D.C. [USA]
Last Updated : Jun 28 2017 | 10:48 AM IST

Acupuncture alone or with the medication may not be effective in treating infertility in women suffering from polycystic ovary syndrome (PCOS), a study has said.

PCOS is a hormonal disorder causing small cysts on the outer edges of the ovaries, which in turn results in them getting enlarged.

Clomiphene is the first-line of treatment used to induce ovulation in women with PCOS.

The findings suggested that active acupuncture, with or without Clomiphene compared to control acupuncture and placebo medication did not increase live births.

Study author Richard S. Legro from Pennsylvania State University in the United States said women undergoing acupuncture with Clomiphene would do much better than women receiving only acupuncture or only clomiphene.

PCOS, which affects an estimated five to 10 percent of women of reproductive age worldwide, is the most common cause of female infertility.

The researchers studied whether or not the traditional Chinese medicine therapy could be a supplemental treatment along with Clomiphene to improve pregnancy outcomes.

They analysed 1,000 Chinese women with PCOS at 21 sites.

The women were divided into four groups in which they received one of four interventions: Clomiphene plus active acupuncture; Clomiphene plus controlled acupuncture (also called placebo acupuncture or mock acupuncture); placebo medication plus active acupuncture; or placebo medication plus controlled acupuncture.

The women were given active or controlled acupuncture twice a week in addition to Clomiphene or placebo medication for five days per ovulation cycle for up to six months.

The researchers kept a tab on all 926 women who had completed the trial for 10 months and beyond.

"There is an impression out there that acupuncture and conventional treatment improves pregnancy success rates, but this study shows acupuncture added nothing beyond medication," Legro said.

The study appears in the Journal of the American Medical Association.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jun 28 2017 | 10:48 AM IST

Next Story